China Pharma Holdings (CPHI) Receivables - Net (2010 - 2026)
China Pharma Holdings' Receivables - Net was $181,621 in Q2 2026, down 32.4% from $268,793 a year earlier and down 7.5% from the prior quarter.
Powered by 
Analysis
China Pharma Holdings (CPHI) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at China Pharma Holdings came in at $241,412, up 4.0% from FY2024.
- Receivables - Net shows a five-year compound annual growth rate of 54.2% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $232,140 in FY2024 (-54.0%), $504,448 in FY2023 (+19.7%), $421,531 in FY2022 and $29,564 in FY2021 (+6.9%).
- The Q2 2026 figure marks the lowest quarterly Receivables - Net since Q1 2023.
- Compared with a year earlier, Receivables - Net was higher in two of the last eight quarters, with an average decline of 21.0%.
- The best year-over-year quarter for Receivables - Net over five years was Q3 2023 (growth of 728.5%); the worst was Q1 2022 (a decline of 92.8%).
- Per Business Quant data, CPHI's Receivables - Net in the three quarters before Q2 2026 was $196,262 (Q1 2026), $241,412 (Q4 2025) and $224,638 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.65 Bn | 1,100.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.89 Bn | 534.41 Bn | 17.26 Bn |
| 3 | AbbVie | 505.03 Bn | 478.14 Bn | 12.70 Bn |
| 4 | Merck | 368.78 Bn | 323.16 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.66 Bn | 262.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 262.09 Bn | 235.78 Bn | 12.86 Bn |
| 7 | Amgen | 236.57 Bn | 191.97 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.05 Bn | 165.25 Bn | 6.22 Bn |
| 9 | Pfizer | 170.60 Bn | 117.25 Bn | 10.94 Bn |
| 10 | China Pharma Holdings | 28.37 Mn | 27.25 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 181,621.00 |
| Mar 31, 2026 | 196,262.00 |
| Dec 31, 2025 | 241,412.00 |
| Sep 30, 2025 | 224,638.00 |
| Jun 30, 2025 | 268,793.00 |
| Mar 31, 2025 | 328,901.00 |
| Dec 31, 2024 | 232,140.00 |
| Sep 30, 2024 | 333,371.00 |
| Jun 30, 2024 | 254,850.00 |
| Mar 31, 2024 | 358,765.00 |
| Dec 31, 2023 | 504,448.00 |
| Sep 30, 2023 | 368,227.00 |
| Jun 30, 2023 | 275,244.00 |
| Mar 31, 2023 | 107,254.00 |
| Dec 31, 2022 | 421,531.00 |
| Sep 30, 2022 | 44,444.00 |
| Jun 30, 2022 | 55,925.00 |
| Mar 31, 2022 | 39,019.00 |
| Dec 31, 2021 | 29,564.00 |
| Sep 30, 2021 | 50,013.00 |
API Access
China Pharma Holdings Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();